Skip to content
← Back to this collection

PUBLICATIONS · 31166680

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Aug 15
First author
Robert C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Strahlenther Onkol. 2019 Oct;195(10):940-942. doi: 10.1007/s00066-019-01504-y.
    note
    Source null
    related pmid
    31418045
    relationship
    Comment in

Authors and identifiers

  1. name
    Robert C
    type
    Author
  2. name
    Grob JJ
    type
    Author
  3. name
    Stroyakovskiy D
    type
    Author
  4. name
    Karaszewska B
    type
    Author
  5. name
    Hauschild A
    type
    Author
  6. name
    Levchenko E
    type
    Author
  7. name
    Chiarion Sileni V
    type
    Author
  8. name
    Schachter J
    type
    Author
  9. name
    Garbe C
    type
    Author
  10. name
    Bondarenko I
    type
    Author
  11. name
    Gogas H
    type
    Author
  12. name
    Mandalá M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robert C
    type
    Author
  2. name
    Grob JJ
    type
    Author
  3. name
    Stroyakovskiy D
    type
    Author
  4. name
    Karaszewska B
    type
    Author
  5. name
    Hauschild A
    type
    Author
  6. name
    Levchenko E
    type
    Author
  7. name
    Chiarion Sileni V
    type
    Author
  8. name
    Schachter J
    type
    Author
  9. name
    Garbe C
    type
    Author
  10. name
    Bondarenko I
    type
    Author
  11. name
    Gogas H
    type
    Author
  12. name
    Mandalá M
    type
    Author
bibliography ids
  1. nci-bib-aa51dc84463344f13339e502
book metadata
content sha256
27aecc6df8fa527201d5a30021014b7b272b5c168c4440fb757bb2cab7d2d152
document type
citation
dois
  1. 10.1056/NEJMoa1904059
electronic publication date
display
2019 Jun 4
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31166680
immutable id
pubmed:31166680@27aecc6df8fa527201d5a30021014b7b272b5c168c4440fb757bb2cab7d2d152
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
7
name
The New England journal of medicine
nlm unique id
0255562
pages
626-636
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Strahlenther Onkol. 2019 Oct;195(10):940-942. doi: 10.1007/s00066-019-01504-y.
    note
    Source null
    related pmid
    31418045
    relationship
    Comment in
outcomes validated
false
pmid
31166680
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
4d0cecc0f0095e57f4e1914e717af420b7a204a2f433ca921751a6d177296715
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Aug 15
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31166680/
title
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

Preserved source evidence · Independent clinical review pending · Not medical advice